A. M. Bonnet

2.2k total citations
17 papers, 688 citations indexed

About

A. M. Bonnet is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, A. M. Bonnet has authored 17 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Neurology, 4 papers in Cellular and Molecular Neuroscience and 3 papers in Molecular Biology. Recurrent topics in A. M. Bonnet's work include Parkinson's Disease Mechanisms and Treatments (12 papers), Neurological disorders and treatments (6 papers) and Genetic Neurodegenerative Diseases (3 papers). A. M. Bonnet is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (12 papers), Neurological disorders and treatments (6 papers) and Genetic Neurodegenerative Diseases (3 papers). A. M. Bonnet collaborates with scholars based in France, United States and Tunisia. A. M. Bonnet's co-authors include Yves Agid, Virginie Czernecki, Albert Villageois, Marie Vidailhet, Merle Ruberg, François Rieger, B. Pillon, Bruno Dubois, Jean‐Christophe Corvol and F Lhermitte and has published in prestigious journals such as Neurology, Brain Research and The Journal of Urology.

In The Last Decade

A. M. Bonnet

17 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. M. Bonnet France 12 497 212 122 103 83 17 688
Prabesh Kanel United States 16 413 0.8× 224 1.1× 164 1.3× 64 0.6× 92 1.1× 43 638
Jean Debarros United Kingdom 8 270 0.5× 258 1.2× 150 1.2× 97 0.9× 52 0.6× 10 526
J. P. Hubble United States 8 475 1.0× 277 1.3× 106 0.9× 77 0.7× 20 0.2× 10 736
E Jaros United Kingdom 6 325 0.7× 167 0.8× 96 0.8× 57 0.6× 126 1.5× 6 648
Maja Trošt Slovenia 16 583 1.2× 266 1.3× 145 1.2× 104 1.0× 17 0.2× 51 812
Allison Dicke United States 6 491 1.0× 145 0.7× 137 1.1× 126 1.2× 26 0.3× 6 612
Carl Sikkema United States 15 128 0.3× 163 0.8× 92 0.8× 69 0.7× 52 0.6× 18 495
Simon Parkin United Kingdom 14 739 1.5× 402 1.9× 115 0.9× 65 0.6× 161 1.9× 14 908
Chiara Logi Italy 14 424 0.9× 93 0.4× 93 0.8× 57 0.6× 38 0.5× 19 636
Jennifer Y. Y. Szeto Australia 12 379 0.8× 55 0.3× 113 0.9× 77 0.7× 48 0.6× 15 625

Countries citing papers authored by A. M. Bonnet

Since Specialization
Citations

This map shows the geographic impact of A. M. Bonnet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. M. Bonnet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. M. Bonnet more than expected).

Fields of papers citing papers by A. M. Bonnet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. M. Bonnet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. M. Bonnet. The network helps show where A. M. Bonnet may publish in the future.

Co-authorship network of co-authors of A. M. Bonnet

This figure shows the co-authorship network connecting the top 25 collaborators of A. M. Bonnet. A scholar is included among the top collaborators of A. M. Bonnet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. M. Bonnet. A. M. Bonnet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Mariani, Louise‐Laure, A. M. Bonnet, Florence Cormier, et al.. (2017). “De-novo” consultation: Evaluation of an outpatient's clinic dedicated to early diagnosis of parkinsonian syndromes. Revue Neurologique. 173(1-2). 55–61. 2 indexed citations
2.
Bonnet, A. M.. (2015). Appendix B: Unified Parkinson's Disease Rating Scale. PubMed. 156(5). 193–197. 12 indexed citations
3.
Bonnet, A. M. & Virginie Czernecki. (2013). Non-motor symptoms in Parkinson's disease: cognition and behavior. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. 11(3). 295–304. 5 indexed citations
4.
Bonnet, Cécilia, Emmanuelle Apartis, Mathieu Anheim, et al.. (2012). Tremor-spectrum in spinocerebellar ataxia type 3. Journal of Neurology. 259(11). 2460–2470. 22 indexed citations
5.
Bonnet, A. M., et al.. (2012). Nonmotor Symptoms in Parkinson’s Disease in 2012: Relevant Clinical Aspects. Parkinson s Disease. 2012. 1–15. 79 indexed citations
6.
Troiano, André R., Ayman El‐Baz, Ebba Lohmann, et al.. (2010). LOW DISEASE RISK IN RELATIVES OF NORTH AFRICAN LRRK2 PARKINSON DISEASE PATIENTS. Neurology. 75(12). 1118–1119. 15 indexed citations
7.
Schüpbach, Michaël, David Maltête, Jean Luc Houeto, et al.. (2006). Neurosurgery at an earlier stage of Parkinson disease. Neurology. 68(4). 267–271. 164 indexed citations
8.
Schüpbach, Michaël, Marie Laure Welter, A. M. Bonnet, et al.. (2006). Mortality in patients with Parkinson's disease treated by stimulation of the subthalamic nucleus. Movement Disorders. 22(2). 257–261. 26 indexed citations
9.
Bonnet, A. M., J. Pichon, Marie Vidailhet, et al.. (1999). Urinary Disturbances in Striatonigral Degeneration and Parkinson's Disease: Clinical and Urodynamic Aspects. The Journal of Urology. 161(6). 2033–2033. 2 indexed citations
10.
Arnulf, Isabelle, et al.. (1999). Dyskinesias assessment in Phase II studies.. PubMed. 14 Suppl 1. 54–9. 5 indexed citations
11.
Bonnet, A. M., J. Pichon, Marie Vidailhet, et al.. (1999). Urinary Disturbances in Striatonigral Degeneration and Parkinson's Disease. The Journal of Urology. 2033–2033. 1 indexed citations
12.
Vidailhet, Marie, A. M. Bonnet, R. Marconi, N. Gouider‐Khouja, & Yves Agid. (1994). Do parkinsonian symptoms and levodopa‐induced dyskinesias start in the foot?. Neurology. 44(9). 1613–1613. 35 indexed citations
13.
Pillon, B., et al.. (1989). Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment. Neurology. 39(6). 762–762. 130 indexed citations
14.
Ruberg, Merle, Albert Villageois, A. M. Bonnet, et al.. (1987). Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems.. Journal of Neurology Neurosurgery & Psychiatry. 50(5). 538–543. 45 indexed citations
15.
Koller, William C., Robert J. O’Hara, William J. Weiner, et al.. (1987). Relationship of aging to Parkinson's disease.. PubMed. 45. 317–21. 39 indexed citations
16.
Bonnet, A. M., et al.. (1986). A Controlled Study of Oral Vigabatrin (ɣ-Vinyl GABA) in Patients with Cerebellar Ataxia. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 13(4). 331–333. 11 indexed citations
17.
Ruberg, Merle, François Rieger, Albert Villageois, A. M. Bonnet, & Yves Agid. (1986). Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's disease. Brain Research. 362(1). 83–91. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026